Sarilumab
Sanofi,regeneron
[]
i find this incredibly encouraging saphyr subanalysis:
refractory pmr
sarilumab (w 14w pnl taper) vs placebo (w 52w taper) ?no sx benefit kicks on after pnl taper stops, out to 52w
reality in practice: bit more pnl prob gives excellent sx outcomes abst1543 #acr22 
Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes podcast host for @austprescriber and others. All opinions my own